Aurobindo Pharma said its subsidiary CuraTeQ Biologics has received a Notice of Compliance from Health Canada for its ...

As of Friday, January 09, Milestone Pharmaceuticals Inc.’s MIST share price has dipped by 5.84%, which has investors ...

In Canada, the patent for some semaglutide drugs has expired, paving the way for the country to become the first to offer ...

Aurobindo Pharma's CuraTeQ Biologics receives Health Canada approval for Dyrupeg, marking a major regulatory milestone for ...

Health Canada is currently considering nine submissions from other drug companies to make generic semaglutide.

UKRI Innovate UK and NRC IRAP provide funding and advisory support, fostering UK-Canada collaboration in genetic medicine ...

From established players to up-and-coming firms, Canada's pharmaceutical landscape is diverse and dynamic. Canadian drug ...

GlobalData’s detailed strategic reports on the MFN executive order and on the GENEROUS model examined how some of the known ...

Online pharmacy platform SaveRxCanada.to said on Wednesday it has begun offering Novo Nordisk's blockbuster diabetes drug, ...

Aurobindo Pharma said its subsidiary CuraTeQ Biologics has received Health Canada’s compliance notice for its biosimilar ...

Cybin Inc. (the “Company”) doing business as Helus Pharma™ (Nasdaq: HELP) (Cboe CA: HELP) (“Helus Pharma”), a clinical stage ...

Health Canada says it has not received an application from the B.C. government to continue the province’s drug ...